Krka Reports Fall in Nine-Month Profit
Ljubljana, 17 November - Pharmaceutical group Krka posted a net profit of EUR 115.4m in the first nine months of 2011, which is 4% less than in the same period last year, while the core company's net profit dropped by 17.3% to EUR 109.2m. The company is planning to list its shares on the Warsaw Stock Exchange by June 2012.
The rest of this news item is available to subscribers.
The news item consists of 839 characters (without spaces) or 174 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.